
About Truvida Pharmaceuticals Private Limited
Data last updated:
Truvida Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2019PTC134838. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Appidi Sindhura and Ravinder Reddy Bommireddy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Survey No.123 Jeedimetla Village Quthbullapur Road, Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2024, the company reported a revenue of ₹66,451. For the same year it recorded a net loss of ₹37,657 (net margin -56.7%) and EBITDA of -₹37,657 (EBITDA margin -56.7%).
For more details, the company can be reached via its website truvidapharma.com.
Company details
Contact details
Truvida Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is truvidapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSurvey No.123 Jeedimetla Village Quthbullapur Road, Hyderabad, Telangana, India – 500055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Truvida Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Truvida Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Truvida Pharmaceuticals Private Limited, buy the company report.
Financials of Truvida Pharmaceuticals Private Limited
FY 2024 filings availableTruvida Pharmaceuticals Private Limited reported revenue of ₹66,451 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹37,657 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹37,657 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -56.7% | ||||
| Net Profit Margin | -56.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Truvida Pharmaceuticals Private Limited, buy the company report.
Board of directors of Truvida Pharmaceuticals Private Limited
Truvida Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Appidi Sindhura Also directs: One Developers Private Limited, Truvida Life Sciences LLP | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
| Ravinder Reddy Bommireddy | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
| Venkata Subbi Reddy Appidi | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
| Vasisht Reddy Bommi | Director | 19 Aug 2019 | 7 Years 2 Months | Current |
Auditor
Truvida Pharmaceuticals Private Limited is audited by M S P R & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M S P R & CO | FY 2022 | 010152S |
Shareholding
The shareholding of Truvida Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Truvida Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Truvida Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Truvida Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Truvida Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Truvida Pharmaceuticals Private Limited, buy the company report.
Recent activity
Truvida Pharmaceuticals Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Appidi Sindhura was appointed as Director on 19 Aug 2019.
Frequently asked questions
Truvida Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 August 2019 (7+ years old) and is registered under CIN U24230TG2019PTC134838.
Truvida Pharmaceuticals has 4 current directors:
- Appidi Sindhura - Director
- Ravinder Reddy Bommireddy - Director
- Venkata Subbi Reddy Appidi - Director
- Vasisht Reddy Bommi - Director
The latest financial statements of Truvida Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
No. Truvida Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Truvida Pharmaceuticals is U24230TG2019PTC134838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Truvida Pharmaceuticals was incorporated on 19 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Appidi Sindhura was appointed as Director on 19 Aug 2019. Ravinder Reddy Bommireddy was appointed as Director on 19 Aug 2019. Vasisht Reddy Bommi was appointed as Director on 19 Aug 2019. Truvida Pharmaceuticals has 4 board changes on record in total.
Truvida Pharmaceuticals can be reached through the website truvidapharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Truvida Pharmaceuticals is at Survey No.123 Jeedimetla Village Quthbullapur Road, Hyderabad, Telangana, India – 500055.
Truvida Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

